Sinagen Company was founded in 1994 with the aim of producing new biotechnology products. A move inspired by the efforts of four well-known specialists led to the birth of the largest manufacturer of medical biotechnology products in the region. Our efforts focused on the development of biochemical products in the fields of immunological diseases, infertility, hormonal disorders and cancer, as well as the provision of research services. And development. The company currently allocates 20% of its total turnover to research and development activities. Our goal is to use our expertise to identify and market selected products through collaborative strategies to promote sustainable human health development. Currently, Sinagen has manufactured its own specialty pharmaceutical biotechnology product portfolio, and in 95 countries it has withdrawn 585 million dollars from the country for the purchase of these drugs, which contributes greatly to the country's economy and the purchasing power of domestic patients that earn two statues And two licenses for the rights of consumers from the Ministry of Industry, Mines and Trade of Iran during the years from 90 to 93 confirmed this point.